GoodRx Holdings (GDRX) Receivables Refunds (2020 - 2022)

GoodRx Holdings' Receivables Refunds history runs 3 years deep, the most recent figure standing at $4.5 million for Q4 2022.

• In Q4 2022, Receivables Refunds fell 45.7% year-over-year to $4.5 million; the TTM figure through Dec 2022 stood at $4.5 million (down 45.7% YoY), while the FY2022 annual figure was $4.5 million, down 45.7% from the prior year.
• Receivables Refunds came in at $4.5 million for Q4 2022 at GoodRx Holdings, up from $2.2 million in the prior quarter.
• In the past five years, Receivables Refunds ranged from a high of $79.8 million in Q2 2021 to a low of $2.2 million in Q3 2022.
• A 3-year average of $24.4 million and a median of $22.3 million in 2021 frame the typical range for Receivables Refunds.
• Across the five-year window, Receivables Refunds fell 3.09% in 2021 and plunged 92.24% in 2022, its largest moves.
• GoodRx Holdings' Receivables Refunds stood at $28.6 million in 2020, then slumped by 70.83% to $8.3 million in 2021, then slumped by 45.7% to $4.5 million in 2022.
• According to Business Quant data, Receivables Refunds over the past three periods registered $4.5 million, $2.2 million, and $16.8 million for Q4 2022, Q3 2022, and Q2 2022 respectively.

Peer Comparison